Physician profile
Austin D Chen
NPI 1770100133
$6,273.31
in general payments reported to CMS, 2019-2025
11 companies · $721 in 2025
The $721 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $263 · 2022: $224 · 2023: $1,905 · 2024: $3,160 · 2025: $721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,965 · Food and Beverage: $2,821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,965.00 |
| Food and Beverage | $2,821.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,966.76 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Revolve |
| Musculoskeletal Transplant Foundation INC. | $651.66 | 2023-2025 | |
| Kerecis Limited | $429.16 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Rti Surgical, INC | $369.77 | 2021-2024 | |
| Mentor Worldwide LLC | $234.66 | 2021-2022 | |
| Integra Lifesciences Corporation | $166.26 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Davol INC. | $106.17 | 2022 | |
| Acera Surgical, INC. | $96.47 | 2024 | Restrata Wound Matrix |
| Coopersurgical, INC. | $95.00 | 2025 | Insorb |
| Axogen | $83.53 | 2023 | Avance Nerve Graft |
| Allergan, INC. | $73.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.